ISRCTN54746861
Completed
Not Applicable
A randomised trial of a community pharmacist-initiated screening and intervention program for osteoporosis: the OsteoPharm Study
niversity of Alberta (Canada)0 sites250 target enrollmentJanuary 26, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Alberta (Canada)
- Enrollment
- 250
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males or females who are:
- •1\. Over the age of 50
- •2\. Considered to be at a high risk for osteoporosis and fractures as defined by the Osteoporosis Society of Canada Clinical Practice guidelines and as defined specifically for the purposes of this study, i.e., are over the age of 65 years or between 50 \- 64 years of age with any one of the following:
- •2\.1\. Family history of osteoporosis
- •2\.2\. Previous fragility fracture
- •2\.3\. Systemic steroids
- •2\.4\. Early menopause (for women)
- •3\. Live in the Capital Health Region (Edmonton Region)
Exclusion Criteria
- •1\. Are unable or unwilling to provide informed consent
- •2\. Are on current prescription treatment for osteoporosis
- •3\. Have had a dual energy x\-ray absortiometry (DEXA) scan performed in the past two years
- •4\. Are non\-English speaking
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
DCMedsRec; Reducing hospital readmission by enhanced My Health Record use in Community Pharmacy. An ADHA Digital Test Beds projectPolypharmacyMedication misadventurePublic Health - Health service researchACTRN12619000282189Eastern Health700
Recruiting
Not Applicable
Community pharmacist-led inhaler choice for improvement of lung function in COPDChronic Obstructive Pulmonary DiseaseJPRN-UMIN000052218Satoshi Dote, Department of Pharmacy, Kyoto-Katsura Hospital.40
Recruiting
Not Applicable
Can a pharmacist-led education and support intervention assist patients to reduce their glucocorticoid (steroid) dose and improve outcomes for patients with rheumatic diseases?Rheumatoid arthritisPolymalgia RheumaticaGiant Cell ArteritisSystemic Lupus ErythematosusInflammatory MyositisInflammatory and Immune System - Rheumatoid arthritisInflammatory and Immune System - Autoimmune diseasesInflammatory and Immune System - Connective tissue diseasesPublic Health - Health service researchACTRN12624000817549Central Adelaide Local Health Network100
Completed
Not Applicable
Pharmacist-led home based clinical medication review in strokeTopic: Stroke Research NetworkSubtopic: Primary CareDisease: Community studyCirculatory SystemStrokeISRCTN57684399HS Lothian (UK)60
Completed
Not Applicable
A randomised controlled trial of a pharmacy care plan for elderly patients discharged from hospital.Pharmacy care for the elderlyNot ApplicableISRCTN66700837Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)